Kalaris Therapeutics, Inc.

8-K Director or officer change Jul 20, 2026 8-K Regulation FD disclosure; Other events Jul 17, 2026 8-K Director or officer change Jul 6, 2026 8-K Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Director or officer change Apr 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Results of operations (earnings release) Mar 17, 2026 8-K Regulation FD disclosure Mar 9, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Dec 18, 2025 8-K Regulation FD disclosure; Other events Dec 17, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Director or officer change Nov 3, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Shareholder vote results Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Item 5.08; Other events Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Director or officer change Apr 16, 2025 8-K Director or officer change Apr 4, 2025 8-K Completed an acquisition or disposition; Results of operations (earnings release); Change in control; Director or officer change; Amended charter or bylaws; Item 5.06; Regulation FD disclosure Mar 18, 2025 8-K Director or officer change; Shareholder vote results; Other events Mar 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 7, 2025 8-K Modified rights of security holders; Amended charter or bylaws Jan 15, 2025 8-K Other events Jan 10, 2025 8-K Shareholder vote results Jan 10, 2025 8-K Director or officer change Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Entered a material agreement; Regulation FD disclosure Nov 8, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Terminated a material agreement Jul 2, 2024 8-K Terminated a material agreement Jun 11, 2024 8-K Shareholder vote results Jun 7, 2024 8-K Director or officer change Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 10-K Fiscal year ended 2023-12-31 Mar 15, 2024 8-K Delisting notice or listing-rule failure Feb 12, 2024